Celgene Corp. buy melinda
Start price
11.10.13
/
50%
€56.45
Target price
23.12.13
€60.00
Performance (%)
9.27%
End price
23.12.13
€61.68
Summary
This prediction ended on 23.12.13 with a price of €61.68. With a performance of 9.27%, the BUY prediction by melinda for Celgene Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celgene Corp. | - | - | - | - |
| iShares Core DAX® | -3.141% | 1.269% | 16.367% | 60.124% |
| iShares Nasdaq 100 | -3.518% | -1.355% | 2.670% | 101.416% |
| iShares Nikkei 225® | -3.396% | 3.283% | 17.041% | 47.915% |
| iShares S&P 500 | -2.943% | -0.533% | 1.373% | 64.215% |
Comments by melinda for this prediction
In the thread Celgene Corp. diskutieren
erhöhen
RBC Capital Markets
(Vom Mitglied beendet)


